| Literature DB >> 29757285 |
Yannig Gicquel1, Robin Schubert2, Svetlana Kapis3, Gleb Bourenkov4, Thomas Schneider4, Markus Perbandt5, Christian Betzel2, Henry N Chapman6, Michael Heymann7.
Abstract
This protocol describes fabricating microfluidic devices with low X-ray background optimized for goniometer based fixed target serial crystallography. The devices are patterned from epoxy glue using soft lithography and are suitable for in situ X-ray diffraction experiments at room temperature. The sample wells are lidded on both sides with polymeric polyimide foil windows that allow diffraction data collection with low X-ray background. This fabrication method is undemanding and inexpensive. After the sourcing of a SU-8 master wafer, all fabrication can be completed outside of a cleanroom in a typical research lab environment. The chip design and fabrication protocol utilize capillary valving to microfluidically split an aqueous reaction into defined nanoliter sized droplets. This loading mechanism avoids the sample loss from channel dead-volume and can easily be performed manually without using pumps or other equipment for fluid actuation. We describe how isolated nanoliter sized drops of protein solution can be monitored in situ by dynamic light scattering to control protein crystal nucleation and growth. After suitable crystals are grown, complete X-ray diffraction datasets can be collected using goniometer based in situ fixed target serial X-ray crystallography at room temperature. The protocol provides custom scripts to process diffraction datasets using a suite of software tools to solve and refine the protein crystal structure. This approach avoids the artefacts possibly induced during cryo-preservation or manual crystal handling in conventional crystallography experiments. We present and compare three protein structures that were solved using small crystals with dimensions of approximately 10-20 µm grown in chip. By crystallizing and diffracting in situ, handling and hence mechanical disturbances of fragile crystals is minimized. The protocol details how to fabricate a custom X-ray transparent microfluidic chip suitable for in situ serial crystallography. As almost every crystal can be used for diffraction data collection, these microfluidic chips are a very efficient crystal delivery method.Entities:
Mesh:
Year: 2018 PMID: 29757285 PMCID: PMC6100780 DOI: 10.3791/57133
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355







|
|
|
|
|
|
|
|
| |||
| 1st layer: Wells | 1000 RPM | 0 / 10 min | 200 mJ/cm2 | 1 / 4 min |
| 15 µm SU8-3010 | ||||
| 2nd layer: Bypass | 2000 RPM | 0 / 16 min | 220 mJ/ cm2 | 1 / 5 min |
| 35 µm SU8-3025 | ||||
| 3rd layer: Valves | 3000 RPM | 0 / 3 min | 150 mJ/ cm2 | 1 / 2 min |
| 5 µm SU8-3005 |
|
|
|
|
|
|
|
| Thaumatin ( | 40 mg mL-1 | 50 mM Bis-Tris, pH 6.5 | 1.1 M sodium tartrate, 50 mM Tris, pH 6.8 | I4222, 1LR2 | 29420 |
| Glucose isomerase ( | 25 mg mL-1 | 10 mM HEPES, 1 mM MgCl2, pH 7.0 | 100 mM Bis-Tris, 2.7 M ammonium sulfate, pH 5.7 | I222, 4ZB2 | 46410 |
| Thioredoxin ( | 34 mg mL-1 | 20 mM Tris-HCl, 5 mM EDTA, 150 mM NaCl, pH 8.0 | 27.5 % PEG1500, 100 mM SPG buffer, pH 6.3 | P41212, 4FYU | 24075 |
|
|
|
|
|
|
|
| Thaumatin ( | 103 | 10 | 1 | 40 | 1LR2 |
| Glucose isomerase ( | 69 | 100 | 0.1 | 80 | 4ZB2 |
| Thioredoxin ( | 68 | 10 | 1 | 40 | 4FYU |
| Data collection statisticsa | thaumatin (Frame 1-20) | glucose isomerase (Frame 1-100) | thioredoxin (Frame 1-10) |
| Beamline | P14 | ||
| Wavelength [Å] | 0.96863 | ||
| Space group | P41212 | I222 | P42212 |
| Unit cell parameters: a = b, c [Å] | 58.62, 151.48 | 93.91, 99.60, 103.04 | 58.45, 151.59 |
| Number of crystals | 101 | 41 | 34 |
| Total oscillation [°] | 10 | 10 | 10 |
| Resolution [Å] | 30.1.1989 (1.95 – 1.89) | 30.1.1975 (1.80 – 1.75) | 30.3.2000 (3.20 – 3.00) |
| Temperature [K] | 296 | 296 | 296 |
| R p.i.m.b | 7.5 (25.5) | 8.8 (28.0) | 9.1 (33.2) |
| Measured reflections | 1553200 | 690000 | 1111196 |
| Unique reflections | 21850 | 48942 | 44449 |
| Average I/σ(I) | 6.07 (1.78) | 5.85 (1.66) | 4.08 (1.47) |
| Mn(I) half-set correlation CC(1/2) | 96.2 (72.2) | 95.8 (68.2) | 97.9 (75.3) |
| Completeness [%] | 99.8 (100.0) | 100.0 (99.9) | 99.9 (100.0) |
| Redundancy | 71.1 | 14.1 | 25 |
|
| |||
| Resolution range [Å] | 1/30/1989 | 1/30/1975 | 3/30/2000 |
| R/ Rfree [%] | 18.8/23.9 | 18.1/20.5 | 18.9/23.1 |
| Protein atoms | 1550 | 3045 | 1129 |
| Water molecules | 51 | 111 | 164 |
| Ligand molecules | 20 | 0 | 0 |
| Rms deviation | |||
| Bond-length [Å] | 0.02 | 0.026 | 0.01 |
| Bond angle [°] | 2.04 | 2.22 | 1.43 |
| B factor [Å2] | |||
| Protein | 22.6 | 20 | 50 |
| Water | 25.1 | 27.1 | 29.7 |
| Ligand | 20.4 | ||
|
| |||
| Most favored regions [%] | 97.67 | 95.32 | 96.13 |
| Allowed regions [%] | 2.44 | 4.16 | 3.64 |
| Generously allowed regions [%] | 0.49 | 0.52 | 0.23 |
| a: Values in parentheses are for the highest resolution shell. | |||
| b: ( |